Transaction

Umbra helped advise on Zilch's debt facility for customer advances and also participated in its pre-Series B equity raise. Series B was ultimately led by Gauss Ventures and M&F Fund, raising $80m at a $500m valuation.

Philip Belamant, Founder and CEO at Zilch explains: “This funding is a demonstration of the confidence and strength of Zilch’s mission and products. By putting the customer first and building direct relationships with each of them, we are doing something no one else in the industry has done before. Zilch is far more than a BNPL company. We will very soon be launching in a number of new countries and continue the testing and rapid rollout of alternate ways for our customers to spend with Zilch". 

Transaction

Umbra funded and advised their portfolio company Hastee on its acquisition of Typs, the leading Spanish Earnings on Demand company. This is an important step forward on Hastee's mission to improve people’s financial health, productivity and liquidity on a global scale and one that Umbra are very excited about.

James Herbert, Founder and CEO of Hastee, explains: "In Typs, we have found a great team who share both our values and mission, and a complementary organisation that provides a foothold in Southern Europe to accelerate our expansion across Europe and beyond".

Jaime Jimenez, CEO and Co-Founder of Typs, stated that “Joining forces with Hastee will truly benefit our clients and their employees. We are now positioned to implement our leading financial wellbeing solutions internationally, providing employees with access to the most comprehensive set of tools and resources to help avoid financial stress, and provide the most value to their organisations".

Transaction

Umbra are delighted to announce the successful conclusion of the first phase of their trade finance program with Northumbrian Medical Supplies. Ross Tomkins and his team have been working hard to provide healthcare services across the globe with critical supplies, and it has been Umbra's pleasure to have partnered with him to finance them. The first phase of the program provided over 1,000,000 items of PPE and we look forward to working together going forward to supply many more.

Ross Tomkins said "We make a great team Umbra Capital Partners. Looking forward to helping even more people over the coming months and years". 

Transaction

Umbra was mandated by Stanley Capital to arrange a bespoke financing facility to facilitate their acquisition of Noden Pharma DAC from its US-listed parent PDL Biopharma. This was the first acquisition by Stanley Capital as part of a thematic buy-and-build in the specialty pharma space, so the focus was on achieving a financing that was flexible and scalable enough to allow for future acquisitions. Alongside their debt advisory work, Umbra also provided Stanley with strategic transaction advice.

Through Umbra's work with the Stanley team, they developed a strong conviction in the investment thesis and so rolled their fees and co-invested in the equity, becoming a significant minority shareholder in the business.

Simon Cottle, Partner at Stanley Capital, said: “The acquisition of Noden is the culmination of years of thematic research into the specialty pharmaceuticals sector, which identified the company as a strong buy and build platform. We look forward to working with Noden’s excellent management team and our industry advisors to build the company into a leading pharma platform, providing essential treatments for patients with unique and difficult to treat conditions.”

Transaction

Umbra has participated in the Signifier Medical Technologies (SMT) $10m Series C Funding Round led by Alan Howard, VC investor and co-founder of Brevan Howard. SMT has designed the first non-surgical, non-invasive and day-time treatment for snoring and obstructive sleep apnoea, which affects the daily lives of over 200 million people in the US and Europe alone. The Umbra team is extremely excited to be part of the journey to commercialise the product that should improve the lives of millions of people globally.

Transaction

Umbra was mandated to arrange a +£100m debt facility for Hastee to allow registered employers to advance their employee's earned pay, on demand.

Umbra ran a competitive process and there was significant interest from debt funds and banks. However, in order achieve maximum flexibility, 100% LTV and minimal dilution, Umbra created a £200m dedicated Hastee debt fund, which entered into a bespoke, flexible revolver credit facility to fund the salary advances. The facility is short duration, insured and secured against payroll receivables. Umbra invested alongside a private bank, families and multi-family offices.

Additionally, Umbra invested a significant minority stake in the business via a combination of own funds and value added members of the Umbra family (with connections to large employers) and rolled the majority of their advisory fees into equity.

Umbra are very excited about the economic and social impact of this transaction and believe every employee should – and will – have access to their earned pay as soon as they earn it, and avoid expensive payday loan providers.

Transaction

When You Move approached Umbra to provide acquisition financing for their purchase of PinLocal. With deal terms already agreed, they needed a partner who could move quickly and structure a bespoke and flexible facility.

Umbra Capital Partners completed due-diligence and negotiated long-form documentation within six weeks to enable the acquisition to take place in a timely manner. As part of their desire to partner with clients and participate in the upside, Umbra took their arrangement fees as equity and will sit on the board of the combined business going forward.

Transaction

Umbra met the founder of HotelMap™ during their initial capital raising efforts and were so impressed by the quality of the team and their ability to tackle the opportunity that they decided to invest personally in the business.

Following impressive growth, Umbra helped the founder determine a fair valuation for the latest round and introduced the transaction to members of the Umbra family, who invested alongside them and added value by offering their expertise and network. The raise was oversubscribed and Umbra is now a significant minority shareholder.

Transaction

Umbra was approached by an equity investor to help structure and arrange a particularly complex MBO under intense time pressure. Umbra structured and arranged a deal to allow five existing partners of the firm to take ownership alongside the external equity investor and ensure incentives are aligned going forward.

Umbra continues to provide support and strategic advisory to the management team and equity investor on an ad-hoc basis.

Transaction

Umbra was approached to provide strategic advisory to Rogue projects. Umbra helped develop hearO™’s business model and leverage their network to help negotiate exclusive partnerships with the likes of Wilson.

Umbra's mandate provides ongoing, strategic business advice, oversight and governance for Rogue projects. Umbra's advisory fees are rolled into equity and they have aligned with the founders' ambitious plan to build special design projects from the studio.

Umbra are enthusiastic about the social impact space.